TriSalus Life Sciences Stock (NASDAQ:MTAC)

Revenue Ownership Financials Chart Transcripts

Previous Close

$9.56

52W Range

$8.43 - $12.83

50D Avg

$10.41

200D Avg

$10.22

Market Cap

$83.86M

Avg Vol (3M)

$13.97K

Beta

-0.02

Div Yield

-

MTAC Company Profile

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Feb 08, 2021

Website

-

MTAC Performance

MTAC Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$18.51M	$12.40M	$8.40M
Operating Income	$-54.15M	$-36.44M	$-24.03M
Net Income	$-59.04M	$-47.19M	$-28.84M
EBITDA	$-53.40M	$-44.59M	$-22.82M
Basic EPS	-	$-1.79	$-1.10
Diluted EPS	-	$-1.79	$-1.10

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q2 24Aug 15, 24 | 2:33 PM

Q1 24May 15, 24 | 11:40 AM

Q4 23Apr 01, 24 | 10:56 AM

Peer Comparison

Ticker	Company
XPAX	Zalatoris II Acquisition Corp.
FLFV	Feutune Light Acquisition Corporation
NCAC	Newcourt Acquisition Corp
WAVS	Western Acquisition Ventures Corp.